The IT workforce reductions come as Moderna’s chief information officer Brad Miller departs after a two-year stint. Story Feb. 13 - Encoded Therapeutics: The gene therapy biotech is laying off ...
Human BioSciences, a leader in biotechnology and wound care solutions, is tackling one of our most pressing health challenges ...
12h
The Modesto Bee on MSNFrom fashion to finance, Modesto high schools offer over a dozen career and technical pathsAll high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
35m
Hosted on MSNModerna Reports 2024 Loss, Eyes Future GrowthModerna ( ($MRNA) ) has released its Q4 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
15h
Hosted on MSNNew Medical Tech That Could Save LivesVarshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...
22h
GlobalData on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Tether invests in Juventus, driving JUV token growth and expanding blockchain in sports after its EU exit due to stablecoin regulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results